TABLE 7.
Results of TNF-IR Combination Therapy
1 Year | 2 Years | |||
Tofa + MTX | ADA + MTX | Tofa + MTX | ADA + MTX | |
Total cost | $25,227,134 | $30,319,508 | $53,022,456 | $61,633,990 |
Cost PMPM | $2.10 | $2.53 | $2.21 | $2.57 |
ACR20 responders | 363 | 352 | 400 | 392 |
Cost per ACR20 responder | $69,575 | $86,164 | $132,500 | $157,273 |
Note: For TNF-IR results, all therapies were administered as combination therapy with MTX. The analysis is based on 528 treated patients. The cost PMPM is based on the total number of 1 million organization (plan) members.
ACR = American College of Rheumatology; ADA = adalimumab; MTX = methotrexate; PMPM = per member per month; TNF-IR = tumor necrosis factor inhibitor inadequate responder; Tofa = tofacitinib.